SARS News and Research

RSS

Study identifies lower viral load in the nasopharyngeal samples of patients infected with SARS-CoV-2 Omicron variant

In a new study, researchers determined if the higher transmission rate of the SARS-CoV-2 Omicron variant is due to a higher viral load compared to the Delta variant.

8 Feb 2022

Efficacy of MVA-CoV2-S vaccination to prevent SARS-CoV-2 cerebral infection and associated damage

Researchers demonstrated that an MVA vector expressing the SARS-CoV-2 spike protein was 100% effective in preventing neuroinvasion and brain damage by SARS-CoV-2 in transgenic mice.

8 Feb 2022

Characterization of the severity of Omicron relative to Delta in England

Researchers assessed the relative risks of hospitalization and death by SARS-CoV-2 Omicron variant compared to those by Delta (B.1.617.2).

8 Feb 2022

Transmission dynamics of Omicron SARS-CoV-2 variant in England during January 2022

Researchers utilized data from the recent rounds of the REACT-1 study to document the transmission dynamics of SARS-CoV-2, mainly focusing on the Omicron variant in England during January 2022.

8 Feb 2022

Thermo Fisher Scientific launches rapid environmental PCR testing solution that detects in-air SARS-CoV-2 pathogens

Thermo Fisher Scientific Inc. today announced the launch of a new rapid environmental test to help in the fight against COVID-19. The Thermo Scientific Renvo Rapid PCR Test is the latest solution in the company’s in-air pathogen surveillance product portfolio. The Renvo Rapid PCR Test is performed on air samples collected using the company’s Thermo Scientific AerosolSense Sampler.

From Thermo Scientific™ AerosolSense™ Sampler 8 Feb 2022

SARS-CoV-2 cytokine storm inhibited by curcumin nanoparticles

In a recent study published in the journal ACS Applied Bio Materials, researchers demonstrated the inhibitory potential of curcumin-encapsulated polysaccharide nanoparticles (CUR−PS-NPs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (CoV2-SP)-stimulated cytokine storm in lung and liver epithelial cells.

8 Feb 2022

Memory B cells induced by mRNA vaccine may help generate antibodies against Omicron

In a recent research article published in the journal of Science Immunology, a team of researchers from Japan performed longitudinal analysis on the cellular composition of receptor-binding domain (RBD) memory B cell subsets and its antibody binding and neutralizing activity against the Beta, Delta, and Omicron variants following the second dose of a messenger ribonucleic acid (mRNA) vaccine.

8 Feb 2022

Assessing the association of COVID-19 and Immunoglobulin A vasculitis in children

In a recent study posted to the Research Square* preprint server, researchers conducted a systematic review to investigate any association between immunoglobulin A (IgA) vasculitis and coronavirus disease 2019 (COVID-19) in children.

8 Feb 2022

Study uncovers a series of natural products that can inhibit the main protease of SARS-CoV-2

The fight against the COVID-19 pandemic is an international scientific challenge regarding the search for strategies to fight the viral infection and prevent its damaging consequences.

7 Feb 2022

Investigating taraxerol as a protease inhibitor against SARS-CoV-2

In a recent study posted to the Research Square preprint* server, a team of researchers investigated the toxicity and absorption, distribution, metabolism, and excretion (ADME) characteristics of a potent herbal drug, taraxerol, in the management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The paper is under consideration for publication in the Structural Chemistry journal.

7 Feb 2022

SARS-CoV-2 infection-induced antibodies may last more than 20 months

A recent research letter published in the JAMA demonstrated the prevalence and the longevity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in coronavirus disease 2019 (COVID-19) unvaccinated United States (US) adults recovered from the disease in the long term.

7 Feb 2022

SARS-CoV-2 Delta variant's effect on COVID-19 vaccine efficacy

In a recent research paper published in the journal Infection, the scientists estimated the transmission and disease severity associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant and the effectiveness of the current coronavirus disease 2019 (COVID-19) vaccines against the same by conducting a literature review. Further, a meta-analysis was conducted to obtain a numeric estimate of the vaccine effectiveness against the Delta variant.

7 Feb 2022

Novel fast-spreading HIV-1 variant found circulating in the Netherlands

Researchers identify 17 individuals who were infected with a highly virulent variant of HIV-1.

7 Feb 2022

Study shows chronic alcohol consumption as a potential risk factor for SARS-CoV-2-infection

In a study posted to the bioRxiv* preprint server, a team of researchers from Germany studied the expression data of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-relevant genes such as angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2), and the G-protein coupled receptor Mas in an alcohol-exposed rodent model infected with SARS-CoV-2.

7 Feb 2022

SARS-CoV-2 infection can elevate the risk of serious complications during pregnancy

Pregnant individuals infected with SARS-CoV-2, the virus that causes COVID-19, are about 40% more likely to develop serious complications or die during pregnancy than those who aren’t infected with the virus, according to a nationwide study led by a University of Utah Health obstetrician.

7 Feb 2022

SARS News and Research

Study identifies lower viral load in the nasopharyngeal samples of patients infected with SARS-CoV-2 Omicron variant

Efficacy of MVA-CoV2-S vaccination to prevent SARS-CoV-2 cerebral infection and associated damage

Characterization of the severity of Omicron relative to Delta in England

Transmission dynamics of Omicron SARS-CoV-2 variant in England during January 2022

Thermo Fisher Scientific launches rapid environmental PCR testing solution that detects in-air SARS-CoV-2 pathogens

SARS-CoV-2 cytokine storm inhibited by curcumin nanoparticles

Memory B cells induced by mRNA vaccine may help generate antibodies against Omicron

Assessing the association of COVID-19 and Immunoglobulin A vasculitis in children

Study uncovers a series of natural products that can inhibit the main protease of SARS-CoV-2

Investigating taraxerol as a protease inhibitor against SARS-CoV-2

SARS-CoV-2 infection-induced antibodies may last more than 20 months

SARS-CoV-2 Delta variant's effect on COVID-19 vaccine efficacy

Novel fast-spreading HIV-1 variant found circulating in the Netherlands

Study shows chronic alcohol consumption as a potential risk factor for SARS-CoV-2-infection

SARS-CoV-2 infection can elevate the risk of serious complications during pregnancy

Novel, rapid and efficient assay for SARS-CoV-2 neutralizing antibodies

Fever the dominant symptom in SARS-CoV-2 Alpha- and Delta-infected children

Pregnant women with COVID-19 may be at greater risk for pregnancy complications

mRNA-based COVID-19 booster vaccination shown to protect against severe omicron infection in macaques

Colchicine holds promise to reduce the risk of severe COVID-19

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News